Restoration of lymphocyte function in Janus Kinase 3-deficient mice by retroviral-mediated gene transfer
- 1 January 1998
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 4 (1) , 58-64
Abstract
Janus kinase-3 (JAK3) deficiency has recently been identified as a cause of severe combined immunodeficiency (SCID) in humans. We used a mouse model of Jak3-deficient SCID to test a gene therapy approach for treatment of this disease. Transfer of a Jak3 retroviral vector to repopulat-ing hematopoietic stem cells resulted in increased numbers of T and B lymphocytes, reversal of hypogammaglobulinemia, restoration of T-cell activation upon stimulation with mitogens, and development of an antigen-specific immune response after immunization. Analysis for vector copy number in lymphoid and myeloid populations showed a large in vivo selective advantage for Jak3-expressing lymphoid cells. These results show that gene replacement is a feasible treatment strategy for this disease and that naturally occurring in vivo selection of corrected cells is an important advantage of this approach.Keywords
This publication has 31 references indexed in Scilit:
- Developmental defects of lymphoid cells in Jak3 kinase-deficient miceImmunity, 1995
- Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid DevelopmentScience, 1995
- T Lymphocyte-Directed Gene Therapy for ADA − SCID: Initial Trial Results After 4 YearsScience, 1995
- Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA − Immunodeficient PatientsScience, 1995
- Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)Nature, 1995
- Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chainImmunity, 1995
- Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cellsNature, 1994
- Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2Nature, 1994
- Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humansCell, 1993
- Overview of Biochemical Abnormalities and Molecular Genetics of Adenosine Deaminase DeficiencyPediatric Research, 1993